{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:25:42Z","timestamp":1790706342548,"version":"4.1.0"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9,27]]},"DOI":"10.1097\/tp.0b013e3182551021","type":"journal-article","created":{"date-parts":[[2012,8,31]],"date-time":"2012-08-31T06:33:21Z","timestamp":1346394801000},"page":"547-561","source":"Crossref","is-referenced-by-count":158,"title":["Wound Healing Complications and the Use of Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation"],"prefix":"10.1097","volume":"94","author":[{"given":"Bj\u00f6rn","family":"Nashan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Citterio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210129","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1097\/01.TP.0000093502.26208.42","article-title":". The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients.","volume":"76","author":"Flechner","year":"2003","journal-title":"Transplantation"},{"key":"R2-2-20210129","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/TP.0b013e318192dd56","article-title":". A systematic approach to minimizing wound problems for de novo sirolimus-treated kidney transplant recipients.","volume":"87","author":"Tiong","year":"2009","journal-title":"Transplantation"},{"key":"R3-2-20210129","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1399-0012.2007.00668.x","article-title":". Risk factors for impaired wound healing in sirolimus-treated renal transplant recipients.","volume":"21","author":"Knight","year":"2007","journal-title":"Clin Transplant"},{"key":"R4-2-20210129","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jss.2011.05.030","article-title":". Renal transplant wound complications in the modern era of obesity.","volume":"173","author":"Kuo","year":"2012","journal-title":"J Surg Res"},{"key":"R6-2-20210129","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0022-5347(05)68928-8","article-title":". The morbidity of prolonged wound drainage after kidney transplantation.","volume":"161","author":"Kiberd","year":"1999","journal-title":"J Urol"},{"key":"R7-2-20210129","first-page":"1920","article-title":"Denny R, et al..","volume":"72","author":"Humar","year":"2001","journal-title":"Are wound complications after a kidney transplant more common with modern immunosuppression Transplantation"},{"key":"R8-2-20210129","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1016\/j.transproceed.2006.10.065","article-title":". Risk factors for wound healing complications in sirolimus-treated renal transplant recipients.","volume":"38","author":"Grim","year":"2006","journal-title":"Transplant Proc"},{"key":"R9-2-20210129","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/01.tp.0000219703.39149.85","article-title":". Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials.","volume":"81","author":"Webster","year":"2006","journal-title":"Transplantation"},{"key":"R10-2-20210129","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1432-2277.2011.01357.x","article-title":"Do wound complications or lymphoceles occur more often in solid organ transplant recipients on mTOR inhibitors A systematic review of randomized controlled trials.","volume":"12","author":"Pengel","year":"2011","journal-title":"Transpl Int"},{"key":"R11-2-20210129","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1034\/j.1600-6143.2003.00185.x","article-title":". Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation.","volume":"3","author":"Valente","year":"2003","journal-title":"Am J Transplant"},{"key":"R12-2-20210129","first-page":"367","article-title":". Obesity and renal transplantation.","volume":"172","author":"Merion","year":"1991","journal-title":"Surg Gynecol Obstet"},{"key":"R13-2-20210129","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.transproceed.2011.05.025","article-title":". Long-term survival of simultaneous pancreas-kidney transplantation: influence of early posttransplantation complications.","volume":"43","author":"Perez-Saez","year":"2011","journal-title":"Transplant Proc"},{"key":"R14-2-20210129","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1097\/01.TP.0000122230.46091.E2","article-title":". Cold ischemia time, surgeon, time of day, and surgical complications.","volume":"77","author":"Seow","year":"2004","journal-title":"Transplantation"},{"key":"R15-2-20210129","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1097\/01.TP.0000123082.31092.53","article-title":". Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus.","volume":"77","author":"Dean","year":"2004","journal-title":"Transplantation"},{"key":"R16-2-20210129","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1097\/01.ju.0000121441.76094.6f","article-title":". The influence of various maintenance immunosuppressive drugs on lymphocele formation and treatment after kidney transplantation.","volume":"171","author":"Goel","year":"2004","journal-title":"J Urol"},{"key":"R17-2-20210129","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00007890-200209150-00015","article-title":". The effect of obesity on renal transplant outcomes.","volume":"74","author":"Johnson","year":"2002","journal-title":"Transplantation"},{"key":"R18-2-20210129","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/01.sla.0000157131.84130.12","article-title":". Risk factors for tissue and wound complications in gastrointestinal surgery.","volume":"241","author":"Sorensen","year":"2005","journal-title":"Ann Surg"},{"key":"R19-2-20210129","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00268-011-0964-3","article-title":". Predictive factors of complications after surgical repair of iatrogenic femoral pseudoaneurysms.","volume":"35","author":"Piffaretti","year":"2011","journal-title":"World J Surg"},{"key":"R20-2-20210129","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/0002-9610(92)90014-I","article-title":"Factors influencing wound dehiscence.","volume":"163","author":"Riou","year":"1992","journal-title":"Am J Surg"},{"key":"R21-2-20210129","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00423-008-0381-8","article-title":". Long-term comorbidity of diabetes mellitus is a risk factor for perineal wound complications after an abdominoperineal resection.","volume":"394","author":"Matsuda","year":"2009","journal-title":"Langenbecks Arch Surg"},{"key":"R22-2-20210129","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bjps.2010.05.025","article-title":"Abdominoplasty in patients with and without pre-existing scars: a retrospective comparison.","volume":"64","author":"Karthikesalingam","year":"2011","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R23-2-20210129","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1432-2277.1996.tb00854.x","article-title":"The impact of midline versus transverse incisions on wound complications and outcome in simultaneous pancreas-kidney transplants: a retrospective analysis.","volume":"9","author":"Douzdjian","year":"1996","journal-title":"Transpl Int"},{"key":"R24-2-20210129","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.transproceed.2005.06.055","article-title":". Comparison of oblique versus hockey-stick surgical incision for kidney transplantation.","volume":"37","author":"Nanni","year":"2005","journal-title":"Transplant Proc"},{"key":"R25-2-20210129","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archsurg.2010.305","article-title":". Ten-year retrospective analysis of incisional herniorrhaphy following renal transplantation.","volume":"146","author":"Chang","year":"2011","journal-title":"Arch Surg"},{"key":"R26-2-20210129","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0022-5347(17)35387-9","article-title":". Post-transplant lymphoceles: a critical look into the risk factors, pathophysiology and management.","volume":"150","author":"Khauli","year":"1993","journal-title":"J Urol"},{"key":"R27-2-20210129","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.TP.0000101822.50960.AB","article-title":". Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation.","volume":"77","author":"Azzola","year":"2004","journal-title":"Transplantation"},{"key":"R28-2-20210129","first-page":"2833","article-title":"Rapamycin inhibits spontaneous and fibroblast growth factor beta-stimulated proliferation of endothelial cells and fibroblasts.","volume":"23","author":"Akselband","year":"1991","journal-title":"Transplant Proc"},{"key":"R29-2-20210129","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1096\/fj.01-0658com","article-title":". Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling.","volume":"16","author":"Humar","year":"2002","journal-title":"FASEB J"},{"key":"R30-2-20210129","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.transproceed.2007.04.013","article-title":". Effect of rapamycin on wound healing: an experimental study.","volume":"39","author":"Ekici","year":"2007","journal-title":"Transplant Proc"},{"key":"R31-2-20210129","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1183\/09031936.02.00281602","article-title":". The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats.","volume":"19","author":"Simler","year":"2002","journal-title":"Eur Resp J"},{"key":"R32-2-20210129","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/00007890-200109270-00004","article-title":". Immune cells and immunosuppression in a porcine bronchial model of obliterative bronchiolitis.","volume":"72","author":"Maasilta","year":"2001","journal-title":"Transplantation"},{"key":"R33-2-20210129","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0041-1345(96)00325-9","article-title":". Antiproliferative effect of rapamycin on growth factor-stimulated human adult lung fibroblasts in vitro may explain its superior efficacy for prevention and treatment of allograft obliterative airway disease in vivo.","volume":"29","author":"Nair","year":"1997","journal-title":"Transplant Proc"},{"key":"R34-2-20210129","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":". Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor.","volume":"8","author":"Guba","year":"2002","journal-title":"Nat Med"},{"key":"R35-2-20210129","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/01.tp.0000246078.09845.9c","article-title":". Everolimus interferes with healing of experimental intestinal anastomoses.","volume":"82","author":"van der Vliet","year":"2006","journal-title":"Transplantation"},{"key":"R36-2-20210129","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1524-475X.2009.00558.x","article-title":". Persistent effects of everolimus on strength of experimental wounds in intestine and fascia.","volume":"18","author":"Willems","year":"2010","journal-title":"Wound Repair Regen"},{"key":"R37-2-20210129","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5002112","article-title":". Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis.","volume":"71","author":"Huber","year":"2007","journal-title":"Kidney Int"},{"key":"R38-2-20210129","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1158\/0008-5472.CAN-10-3192","article-title":". Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer.","volume":"71","author":"Patel","year":"2011","journal-title":"Cancer Res"},{"key":"R39-2-20210129","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1349-7006.2007.00439.x","article-title":". Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis.","volume":"98","author":"Kobayashi","year":"2007","journal-title":"Cancer Sci"},{"key":"R40-2-20210129","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1399-0012.2007.00756.x","article-title":". Mycophenolate mofetil vs. sirolimus in kidney transplant recipients receiving tacrolimus-based immunosuppressive regimen.","volume":"22","author":"Sampaio","year":"2008","journal-title":"Clin Transplant"},{"key":"R41-2-20210129","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1600-6143.2005.01193.x","article-title":". Tacrolimus combined with two different dosages of sirolimus in kidney transplantation: results of a multicenter study.","volume":"6","author":"Vitko","year":"2006","journal-title":"Am J Transplant"},{"key":"R42-2-20210129","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1399-0012.2004.00113.x","article-title":". An open-label randomized trial of the safety and efficacy of sirolimus vs. azathioprine in living related renal allograft recipients receiving cyclosporine and prednisone combination.","volume":"18","author":"Machado","year":"2004","journal-title":"Clin Transplant"},{"key":"R43-2-20210129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(00)02480-6","article-title":"Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group.","volume":"356","author":"Kahan","year":"2000","journal-title":"Lancet"},{"key":"R44-2-20210129","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/j.1600-6143.2011.03573.x","article-title":". The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients.","volume":"11","author":"Flechner","year":"2011","journal-title":"Am J Transplant"},{"key":"R45-2-20210129","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/j.ajkd.2009.09.004","article-title":". Tubular toxicity in sirolimus- and cyclosporine-based transplant immunosuppression strategies: an ancillary study from a randomized controlled trial.","volume":"55","author":"Franz","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R46-2-20210129","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1097\/TP.0b013e3181db09e4","article-title":". Thymoglobulin induction and sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids.","volume":"89","author":"Glotz","year":"2010","journal-title":"Transplantation"},{"key":"R47-2-20210129","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/TP.0b013e318160d3c9","article-title":". Prospective comparison of the use of sirolimus and cyclosporine in recipients of a kidney from an expanded criteria donor.","volume":"85","author":"Durrbach","year":"2008","journal-title":"Transplantation"},{"key":"R48-2-20210129","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1111\/j.1600-6143.2007.01976.x","article-title":". Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids.","volume":"7","author":"Buchler","year":"2007","journal-title":"Am J Transplant"},{"key":"R49-2-20210129","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1097\/01.tp.0000235823.09788.f6","article-title":". Living related kidney transplantation without calcineurin inhibitors: initial experience in a Mexican center.","volume":"82","author":"Martinez-Mier","year":"2006","journal-title":"Transplantation"},{"key":"R50-2-20210129","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1600-6143.2005.00885.x","article-title":". A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipientsan interim analysis.","volume":"5","author":"Kandaswamy","year":"2005","journal-title":"Am J Transplant"},{"key":"R51-2-20210129","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/00007890-200004150-00009","article-title":". Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients.","volume":"69","author":"Kreis","year":"2000","journal-title":"Transplantation"},{"key":"R52-2-20210129","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/00007890-200210270-00002","article-title":". Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine.","volume":"74","author":"Flechner","year":"2002","journal-title":"Transplantation"},{"key":"R53-2-20210129","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/00007890-199904150-00017","article-title":". Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group.","volume":"67","author":"Groth","year":"1999","journal-title":"Transplantation"},{"key":"R54-2-20210129","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-2125.2007.02934.x","article-title":". Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients.","volume":"64","author":"Pescovitz","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"R55-2-20210129","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1097\/01.TP.0000141094.34903.54","article-title":". Everolimus (Certican) 12-month safety and efficacy versus mycophenolate mofetil in de novo renal transplant recipients.","volume":"78","author":"Vitko","year":"2005","journal-title":"Transplantation"},{"key":"R56-2-20210129","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.TP.0000164352.65613.24","article-title":". Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: a 3-year randomized, multicenter, phase III study.","volume":"80","author":"Lorber","year":"2005","journal-title":"Transplantation"},{"key":"R57-2-20210129","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1600-6143.2010.03129.x","article-title":". Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients.","volume":"10","author":"Tedesco Silva","year":"2010","journal-title":"Am J Transplant"},{"key":"R58-2-20210129","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/TP.0b013e3181aa7d87","article-title":". Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.","volume":"88","author":"Albano","year":"2009","journal-title":"Transplantation"},{"key":"R59-2-20210129","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/00016340903568175","article-title":". Wound length and corticosteroid administration as risk factors for surgical-site complications following lymphocele section.","volume":"89","author":"De Vivo","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R60-2-20210129","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/01.TP.0000101495.22734.07","article-title":". A randomized long-term trial of tacrolimussirolimus versus tacrolimusmycophenolate mofetil versus cyclosporine (NEORAL)sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year.","volume":"77","author":"Ciancio","year":"2004","journal-title":"Transplantation"},{"key":"R61-2-20210129","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1093\/ndt\/gfp778","article-title":". Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the SYMPHONY study.","volume":"25","author":"Ekberg","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R62-2-20210129","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/j.1432-2277.2010.01094.x","article-title":". Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial.","volume":"23","author":"Dantal","year":"2010","journal-title":"Transpl Int"},{"key":"R64-2-20210129","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/TP.0b013e3181bb43ec","article-title":". Everolimus with very low-exposure cyclosporine A in de novo kidney transplantation: a multicenter, randomized, controlled trial.","volume":"88","author":"Salvadori","year":"2009","journal-title":"Transplantation"},{"key":"R65-2-20210129","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1600-6143.2004.00389.x","article-title":". Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies.","volume":"4","author":"Vitko","year":"2004","journal-title":"Am J Transplant"},{"key":"R66-2-20210129","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/FTD.0b013e3181e44260","article-title":". Mycophenolic acid displays IMPDH-dependent and IMPDH-independent effects on renal fibroblast proliferation and function.","volume":"32","author":"Petrova","year":"2010","journal-title":"Ther Drug Monit"},{"key":"R67-2-20210129","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/archsurg.135.11.1265","article-title":". Effects of steroids and retinoids on wound healing.","volume":"135","author":"Wicke","year":"2000","journal-title":"Arch Surg"},{"key":"R68-2-20210129","first-page":"277","article-title":"Steroids, retinoids, and wound healing.","volume":"11","author":"Anstead","year":"1998","journal-title":"Adv Wound Care"},{"key":"R69-2-20210129","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1016\/j.transproceed.2006.10.047","article-title":". Changes in abdominal wounds following treatment with sirolimus and steroids in a rat model.","volume":"38","author":"Gaber","year":"2006","journal-title":"Transplant Proc"},{"key":"R70-2-20210129","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1245\/s10434-011-1594-6","article-title":". Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy.","volume":"18","author":"Greenblatt","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"R71-2-20210129","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/archderm.143.10.1267","article-title":"Wound complications following diagnostic skin biopsies in dermatology inpatients.","volume":"143","author":"Wahie","year":"2007","journal-title":"Arch Dermatol"},{"key":"R72-2-20210129","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1399-0012.2008.00890.x","article-title":". Steroid withdrawal five days after renal transplantation allows for the prevention of wound-healing complications associated with sirolimus therapy.","volume":"23","author":"Sandrini","year":"2009","journal-title":"Clin Transplant"},{"key":"R73-2-20210129","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/ndt\/gfm621","article-title":". A randomized exploratory trial of steroid avoidance in renal transplant patients treated with everolimus and low-dose cyclosporine.","volume":"23","author":"Montagnino","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R74-2-20210129","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/01.tp.0000173378.28790.0b","article-title":". Comparison of steroid avoidance in tacrolimusmycophenolate mofetil and tacrolimussirolimus combination in kidney transplantation monitored by surveillance biopsy.","volume":"80","author":"Kumar","year":"2005","journal-title":"Transplantation"},{"key":"R75-2-20210129","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1432-2277.2009.00858.x","article-title":". Practical recommendations for the early use of mTOR inhibitors (sirolimus) in renal transplantation.","volume":"22","author":"Campistol","year":"2009","journal-title":"Transplant Int"},{"key":"R76-2-20210129","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/TP.0b013e3181613e65","article-title":". Poor tolerance of sirolimus in a steroid avoidance regimen for renal transplantation.","volume":"85","author":"Smith","year":"2008","journal-title":"Transplantation"},{"key":"R77-2-20210129","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":". Reduced exposure to calcineurin inhibitors in renal transplantation.","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"R78-2-20210129","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1681\/ASN.2007060662","article-title":"Resolved: in minimizing kidney transplant immunosuppression, steroids should go before calcineurin inhibitors: pro.","volume":"18","author":"Matas","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"296","key":"R79-2-20210129","first-page":"37","article-title":"Healing of foot ulcers in immunosuppressed renal transplant patients.","author":"Fletcher","year":"1993","journal-title":"Clin Orthop Relat Res"},{"key":"R80-2-20210129","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.transproceed.2011.03.082","article-title":". Laparoscopic incisional hernia repair after solid-organ transplantation.","volume":"43","author":"Scheuerlein","year":"2011","journal-title":"Transplant Proc"},{"key":"R81-2-20210129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.athoracsur.2007.02.056","article-title":". Uneventful thoracic healing with everolimus after aortic valve replacement.","volume":"84","author":"Pascual","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"R82-2-20210129","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/01.tp.0000228900.24951.66","article-title":". Delayed gastric ulcer healing associated with sirolimus.","volume":"82","author":"Altomare","year":"2006","journal-title":"Transplantation"},{"key":"R83-2-20210129","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/j.1600-6143.2005.01082.x","article-title":". Sirolimus-induced ulceration of the small bowel in islet transplant recipients: report of two cases.","volume":"5","author":"Molinari","year":"2005","journal-title":"Am J Transplant"},{"key":"R84-2-20210129","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1399-0012.2005.00332.x","article-title":". Gastrointestinal hemorrhage due to complicated gastroduodenal ulcer disease in liver transplant patients taking sirolimus.","volume":"19","author":"Smith","year":"2005","journal-title":"Clin Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0b013e3182551021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T20:50:27Z","timestamp":1714337427000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201209270-00002"}},"subtitle":["A Critical Review of the Literature"],"short-title":[],"issued":{"date-parts":[[2012,9,27]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3182551021","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9,27]]}}}